Pharmacy Benefit Management

From Specialty Pharmacy News - Although biosimilars have been hailed as a cost-lowering tool for expensive biologics, so far they haven’t quite achieved their full potential. But a second biosimilar to Johnson & Johnson’s Remicade (infliximab) that launched in late July may be the first true test — and so far, it looks promising. Read more

From Drug Benefit News - Express Scripts Holding Co. says it’s leveraging a software application that combines utilization management, fraud prevention, care management interventions and other tools to reduce opioid misuse. The PBM’s announcement comes as a White House panel, headed by New Jersey Gov. Chris Christie (R), is calling for federal intervention on the crisis. But despite many efforts in the federal and private sector to curtail the crisis, many, including Christie, say the… Read more

Pharmacy Benefit Management Blog

By Angela Maas - May 18, 2017
On Thursday, Vertex Pharmaceuticals Inc. said it was adding Maxor National Pharmacy Services, LLC to its specialty pharmacy network on Aug. 1. Maxor is certainly not a newcomer to the industry and brings a wealth of experience and knowledge, so the move is no surprise. But what might be a surprise...
By Lauren Flynn Kelly - April 14, 2016
In the latest squabble between drugstores and PBMs, the National Community Pharmacists Association (NCPA) on April 1 issued a letter to CMS Deputy Director Cynthia Tudor asserting that Medicare Part D plans and PBMs are not complying with a federal requirement to use drug pricing standards that “...
By Angela Maas - March 30, 2016
As high drug prices continue to make headlines and draw congressional ire, hepatitis C drugs and “Mr. Wu-Tang” Martin Shkreli seem to be getting a reprieve as focus turns to the prostate cancer drug Xtandi. On March 28, 12 members of Congress sent a letter to HHS Sec. Sylvia Burwell and Francis...

It's quick and easy to sign up for FREE access to!

Why do I need to register?